
Steroid Use During ICI Treatment Lessens Effectiveness in Patients With NSCLC
High doses of steroids, whether administered before or during treatment with an immune checkpoint inhibitor (ICI), caused the tumors of patients with non-small cell lung cancer (NSCLC) to shrink less than those not on steroids, according to recent study …